Preferred Label : statine;
MeSH note : amine component of pepstatin; structure;
MeSH CAS label : 4-amino-3-hydroxy-6-methylheptanoic acid;
MeSH Related Number : 49642-07-1 (statine);
Registry Number MeSH : 49642-07-1;
Chemical formula : C8H17NO3;
Is substance : O;
UNII : YTC77XR1EK;
Origin ID : C013165;
UMLS CUI : C0075191;
Automatic exact mappings (from CISMeF team)
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
https://minerva-ebp.be/FR/Analysis/872
2024
Belgium
critical appraisal or critical reading
statine
Breast Cancer Anti-Estrogen Resistance Protein 1
Case
snacks
chronic renal failure syndrome, nos
Supernumerary
BCAR1 wt Allele
No Effect
Coronavirus Anxiety Scale
renal dialysis
Outcome of Therapy
True Case Status
Effect, Appearance
CTNND1 wt Allele
Chronic Kidney Disease
Case Dosing Unit
Packaging Case
Catenin Delta-1
renal insufficiency, chronic
No Cases Transmission Pattern
hydroxymethylglutaryl-coa reductase inhibitors
HMG-CoA Reductase Inhibitor
---
https://www.cochrane.org/fr/CD014769/CENTRALED_la-prise-de-statines-empeche-t-elle-la-formation-de-caillots-sanguins-dans-les-veines-des-personnes
2024
United Kingdom
review of literature
french abstract
veins
blood clot, nos
statine
persons
hydroxymethylglutaryl-coa reductase inhibitors
---
https://minerva-ebp.be/FR/Analysis/843
2023
Belgium
critical appraisal or critical reading
Strategy
hydroxymethylglutaryl-coa reductase inhibitors
HMG-CoA Reductase Inhibitor
statine
Agent Administration
secondary disease, nos
coronary disease
Administrative Activity
administration
Coronary Artery Disease
secondary prevention
Secondary Prevention
organization and administration
---
https://www.cfp.ca/content/69/5/e108
2023
Canada
journal article
symptom, nos
muscle, nos
hydroxymethylglutaryl-coa reductase inhibitors
statine
risk-taking
syndrome
Symptom
---
https://minerva-ebp.be/FR/Article/2330
2023
Belgium
critical appraisal or critical reading
statine
Disease
aspirin
disease of cardiovascular system, nos
Diseases of the cardiovascular system
combined modality therapy
preventive treatment, nos
hypotensive agent, nos
statine
cardiovascular diseases
Antihypertensive agents
principal
acetylsalicylic acid
antihypertensive agents
primary prevention
Diseases
cardiovascular prevention
association
hydroxymethylglutaryl-coa reductase inhibitors
---
https://www.ssmg.be/wp-content/uploads/RMG/375/RMG375_06-11.pdf
2020
Belgium
journal article
principal
primary prevention
statine
hydroxymethylglutaryl-coa reductase inhibitors
amino acids
---